IN8bio, Inc. Form 8-K Summary
Business Context and Reporting Period
IN8bio, Inc. filed this Current Report on August 8, 2022, in connection with a proposed securities offering and related Form S-1 registration statement. The reported period is the three and six months ended June 30, 2022.
Preliminary Financial Metrics
| Metric | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2022 |
|---|---|---|
| Estimated net loss | Approximately $7.2 million | Approximately $13.3 million |
- Estimated cash as of June 30, 2022: approximately $25.7 million.
- Common shares outstanding as of June 30, 2022: 18,838,471.
- The filing does not provide revenue, gross margin, operating cash flow, free cash flow, debt, or liquidity runway figures beyond the estimated cash balance.
Changes, Outlook, and Risks
- No prior-period comparative figures or quantified changes were provided in this 8-K.
- No formal financial guidance or management outlook was provided.
- The estimates are preliminary and are not a comprehensive presentation of financial results. They had not been audited, reviewed, or compiled by the independent registered public accounting firm.
- Actual cash and share counts could differ after completion of quarter-end closing and review procedures.
- The filing relates to a proposed offering; its potential size, pricing, dilution, and use of proceeds are not provided in the text.
- The Item 2.02 information was not deemed “filed” for purposes of Section 18 of the Exchange Act and was not incorporated by reference into other filings except by express reference.
Key Facts for Investors to Verify
- Final second-quarter and year-to-date financial results in the subsequent periodic filing.
- Final cash balance and any changes resulting from quarter-end closing procedures.
- Final shares outstanding and the effect of the proposed offering on dilution.
- Offering terms, proceeds, and expected cash runway disclosed in the Form S-1 and related filings.
- Debt, operating cash burn, revenue, and clinical-development funding requirements, which are not quantified in this 8-K.